The effect of open label UT15 or bosentan on...

The effect of open label UT15 or bosentan on hospitalisation days in patients with pulmonary arterial hypertension (PAH)

A.M Keogh, K.M Brown, C.A Corrigan, C Allada, Y Ten
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
21
Year:
2002
Language:
english
DOI:
10.1016/s1053-2498(01)00723-9
File:
PDF, 77 KB
english, 2002
Conversion to is in progress
Conversion to is failed